TAG HIV Basic Science, Vaccines, and Cure Project Blog
By Richard Jefferys, Project Director at Treatment Action Group (TAG).
recent posts
- HIV Cure Research at AIDS 2026
- In The News: CAR-T Cells for HIV
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the March 2026 Update
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the February 2026 Update
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the December 2025 and January 2026 Updates
Category: Analytical treatment interruptions
-
There are 14 updates in the June 2024 revision to TAG’s listing. New Additions Three newly registered studies have been added: two interventional and one observational. The German company Hookipa Biotech is sponsoring a clinical trial assessing two therapeutic HIV vaccine candidates based on an arenavirus vector platform in people with HIV on antiretroviral…
-
The April 2024 update to TAG’s listing features eight changes. New Additions Three new studies were added this month. All are protocols being initiated by the U.S. government-funded ACTG Network (formerly known as the AIDS Clinical Trials Group, recently revised to Advancing Clinical Therapeutics Globally). The Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa…
-
The March 2024 revision to TAG’s listing includes 26 updates. The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver from March 3-6, and the addition of links to results from HIV cure-related studies presented at the meeting typically makes this the busiest month for changes — hence the delay to this…
-
A total of nine changes were made to TAG’s listing for the February 2024 update. New Additions Two new clinical trials have been added, both not yet open for enrollment. Researchers at the City of Hope Medical Center in Los Angeles are planning to initiate a trial of a novel approach to chimeric antigen receptor…
-
A total of eight changes were made to TAG’s listing for the first monthly update of 2024. New Additions One new study has been added from the Pan African Clinical Trials Registry: Scientists affiliated with the Centre for the AIDS Programme of Research in South Africa (CAPRISA) are launching a phase I cure-related trial investigating…
-
No new HIV cure-related trials or studies were added to the clinicaltrials.gov registry over the past month. A total of seven updates were made to TAG’s listing: A clinical trial in Barcelona, Spain investigating the effects of the drug dasatinib on HIV persistence and inflammation is now open for enrollment. Dasatinib is a tyrosine kinase…
-
No new HIV cure-related trials or studies were added to the clinicaltrials.gov registry over the past month. A total of eight updates have been made to TAG’s listing: A phase II study sponsored by AbbVie that was added to the listing in September (see prior blog update) is now open for enrollment. The company initiated…
-
No new HIV cure-related trials or studies have been added to the clinicaltrials.gov registry over the past month. Two trials in the listing have changed status: A study sponsored by the ANRS in France investigating the link between specific immune system genetics (MHC B35/53Bw4TTC2) and post-treatment control of HIV is now open for enrollment. Participants…
-
There are twelve updates to the listing this month: four new interventional trials and one observational study have been added (all yet to start recruiting), a planned observational study was withdrawn, a trial of immunomodulators has begun recruiting in China, one trial has shifted to the completed studies table, and links to presentations/publications describing results…
-
There are ten updates this month: a newly entered therapeutic HIV vaccine trial in China, a new observational study in Belgium, one observational study shifted to the completed studies table, and links added to presented/published results for seven of the studies in the listing. The therapeutic HIV vaccine trial is testing a novel DNA construct…